Pulse Biosciences
PLSE
45 hedge funds and large institutions have $29.3M invested in Pulse Biosciences in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 3 closing their positions.
4,563% more call options, than puts
Call options by funds: $373K | Put options by funds: $8K
171% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 7
0.39% more ownership
Funds ownership: 10.1% → 10.49% (+0.39%)
0% more funds holding
Funds holding: 45 → 45 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
10% less capital invested
Capital invested by funds: $32.4M → $29.3M (-$3.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$253K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$234K |
| 3 |
Morgan Stanley
New York
|
+$183K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$143K |
| 5 |
State Street
Boston,
Massachusetts
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$32K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$28.5K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$23K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$12.3K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$8.8K |
PLSE Hedge Fund Activity: Q4 2019 in Review
45 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2019, worth a combined $29.3M — down 9.7% from $32.4M a quarter earlier.
Fund positioning in PLSE was balanced in Q4 2019: 3 funds opened new positions, 3 closed out, 19 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $253K. The largest seller was Victory Capital Management, exiting entirely with an estimated $32K sold.
- 45 institutional investors held Pulse Biosciences (PLSE) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $29.3M of Pulse Biosciences stock for Q4 2019, down 9.7% quarter-over-quarter.
- 3 funds opened new Pulse Biosciences positions in Q4 2019 and 3 closed out, a net change of 0 holders.
- The largest Pulse Biosciences buyer in Q4 2019 was Vanguard Group, an estimated $253K added.
- The largest Pulse Biosciences seller in Q4 2019 was Victory Capital Management, an estimated $32K sold.
Based on aggregated 13F filings for Q4 2019.